SPY447.88+3.71 0.84%
DIA348.82+2.35 0.68%
IXIC15,161.53+123.77 0.82%

Precision BioSciences Secures License to Tiziana's Foralumab for Development of Cancer Treatment

MT Newswires · 09/02/2021 00:05

Please log in to view news